Study of Novel Antiretrovirals in Participants With HIV-1

Clinical trial NCT05585307 · COMPLETED

Trial details

NCT number: NCT05585307
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2022-10-26
Primary completion: 2024-02-17
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.